Jefferies LLC |
Cowen and Company, LLC |
Piper Jaffray & Co. |
520 Madison Avenue |
599 Lexington Avenue |
800 Nicolette Mall |
New York, NY 10022 |
New York, New York 10022 |
Minneapolis, Minnesota 55402 |
May 6, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: |
|
Milestone Pharmaceuticals Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-230846 |
Dear Sir/Madam:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended (the Act), we, as representatives of the several Underwriters, wish to advise you that approximately 935 copies of the Preliminary Prospectus included in the Registration Statement on Form S-1 were distributed during the period April 29, 2019 through the date hereof, to prospective underwriters, institutions, dealers and others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
In accordance with Rule 461 of the Act, we hereby join in the request of Milestone Pharmaceuticals Inc. for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 p.m. Eastern time on May 8, 2019, or as soon thereafter as practicable.
[Remainder of page intentionally left blank]
|
Very truly yours, | |
|
|
|
|
By: |
JEFFERIES LLC |
|
|
|
|
By: |
/s/ Matthew Kim |
|
|
Name: Matthew Kim |
|
|
Title: Managing Director |
|
|
|
|
|
|
|
By: |
COWEN AND COMPANY, LLC |
|
|
|
|
By: |
/s/ Chris Swindle |
|
|
Name: Chris Swindle |
|
|
Title: Managing Director |
|
|
|
|
|
|
|
By: |
PIPER JAFFRAY & CO. |
|
|
|
|
By: |
/s/ Chad Huber |
|
|
Name: Chad Huber |
|
|
Title: Managing Director |
[Signature page to Acceleration Request Letter]